Previous Close | 0.0250 |
Open | 0.0250 |
Bid | 0.0250 x 0 |
Ask | 0.0350 x 0 |
Day's Range | 0.0250 - 0.0250 |
52 Week Range | 0.0150 - 0.0400 |
Volume | |
Avg. Volume | 2,349 |
Market Cap | 1.35M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0200 |
Earnings Date | May 25, 2024 - May 29, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10.00 |
Waverley Pharma Inc. ("Waverley Pharma" or the "Company") (TSXV: WAVE), a Canadian pharmaceutical company, is announcing a business update.
Waverley Pharma Inc. ("Waverley Pharma" or the "Company") (TSXV: WAVE), a Canadian pharmaceutical company, is pleased to announce that effective today, Larry Thiessen has been appointed to the Company's Board of Directors. Mr. Thiessen replaces Hellen Siwanowicz, who has resigned from her board position.